期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

超声造影成像在肝脏的应用

Application of contrast-enhanced ultrasound in liver
下载PDF
导出
摘要 超声造影经过40余年的研究发展到目前已经成为一种稳定、安全的影像检查方法,其在肝脏病变中有突出的应用价值,特别是在肝脏局灶性病变、肿瘤介入性治疗术后的跟踪监测及评价、肝硬化的检测评价、肝脏移植术、布-加氏综合征等方面,超声造影大大改善了超声检查的敏感性及准确性,为各类肝脏疾病的诊断提供了重要依据及积极信息。 Contrast- enhanced ultrasound has been a kind of stable and safe method in ultrasonic imaging diagnosis through over 40 year＇s study and development. It has prominent value in diagnosis of liver diseases, especially in focal lesion of liver, monitoring and evaluation after tumor＇s interventional therapy, cirrhosis of the liver, transplant of liver, Budd - Chiari syndrome, and so on. Contrast- enhanced ultrasound can promote sensitivity and accuracy in ultrasonic diagnosis, and then provide important information for diagnosis of liver diseases.
作者 施源 张新力 陈重
机构地区 解放军
出处 《临床超声医学杂志》 2005年第5期335-337,共3页 Journal of Clinical Ultrasound in Medicine
关键词 超声造影 肝脏 超声造影 肝脏病变 肝脏局灶性病变 布-加氏综合征 成像 影像检查方法 介入性治疗 肝脏移植术 跟踪监测 Contrast- enhanced Ultrasound Liver
分类号 R735.704 [医药卫生—肿瘤] R575 [医药卫生—消化系统]
  • 相关文献

参考文献19

  • 1Correas JM, Bridal L, Lesavre A, et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol, 2001,11(8):1 316～ 1 328.
  • 2Burns P. Contrast ultrasound technology. in Contrast - enhanced ultrasound of liver diseases, L. Solbiati, Editor. 2003, Springer: Milan. 1 ～ 18.
  • 3Albrecht T, Blomley MJ. Characteristics of hepatic hemangiomas at contrastenhanced harmonic US. Radiology, 2001,220(1) :269 ～ 270.
  • 4Strobel D, Hoefer A, Martus EG, et al. Dynamic contrast - enhanced power Doppler sonography improves the differential diagnosis of liver lesions. Iht J Colorectal Dis, 2001.16(4) :247 ～ 256.
  • 5Dill - Macky M J, Burns PN, Khalili K, et al. Focal hepatic masses: enhancement patterns with SH U 508A and pulse - inversion US. Radiology, 2002,222(1) :95 ～ 102.
  • 6Hohmann J, Skrok J, Puls R, et al. Characterization of focal liver lesions with contrast - enhanced low Mi real time ultrasound and SonoVue. Rofo, 2003,175(6) :835 ～ 843.
  • 7Quaia E, Stacul F, Bertolotto M, et al. Characterization of focal liver lesions with pulse inversion har- monic imaging (PIHI) using a second generation US contrast agent. Acad Radiol, 2002,9 Suppl 2:376 ～ 379.
  • 8Leen E. The role of contrast - enhanced ultrasound in the characterization of focal liver lesions. Eur Radiol, 2001.11 Suppl 3:27 ～ 34.
  • 9Quaia E, Degobbis F, Tona G, et al. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Mod (Torino), 2004,107(3): 155 ～ 65.
  • 10Bryant TH, Blomley M J, Albrecht T, et al. Liver phase uptake of a liver specific microbubble improves characterization of live lesions: a multicenter study. Radiology (In press), 2004,232(3) :799 ～ 809.

二级参考文献46

  • 1[1]Robert F, Mattrey J. Ultrasound contrast applications in r adiology. Presented in 4th heart center European symposium on ul trasound contrast imaging. Jan, 1999.
  • 2[2]Fuminori Moriyasu. In vivo behavior of microbubbles observed using harmonic gray scale imaging[C].Presented in 4th heart center European symposium on ultrasound contrast inaging. Jan,1999.
  • 3[3]Hancock J, Dittrich H, Jewitt DE, et al. Evaluation of myocardial, hepati c, and renal perfusion in a variety of clinical conditions using an intravenous ul trasound contrast agent (Optison) and second harmonic imaging [J]. Heart, 1999 , 81(6):636-641.
  • 4[4]Forsberg F, Liu JB, Chiou HJ, et al. Comparison of fundamental and wideba nd harmonic contrast imaging of liver tumors [J]. Ultrasonics, 2000, 38(3):110- 113.
  • 5[5]Porter TR, Xie F. Improved myocardial contrast with second harmonic trans ie nt ultrasound response imaging in human using intravenous perfluorocarbon-expos ed sonicated dextrose albumin[J]. JACC, 1996, 27(6): 1497-1501.
  • 6[6]Verbeek XA, Ledoux LA, Willigers JM, et al. Experimental investigation of t he pulse inversion technique for imaging ultrasound contrast agents [J]. J Aco ust Soc Am, 2000, 107(4): 2281-2290.
  • 7[7]Schlief R, Bauer A, Mahler M, et al. LOC-imaging with SHU563A in humans -results of a phase I clinical trial[C]. Presented in 2nd heart center European symposium on ultrasound contrast imaging. Jan, 1997.
  • 8[8]Albrecht T, Blomley MJK, Cosgrove DO, et al. Microbubble enhanced dynamic hepatic Doppler venogaphy a promising novel technique for the noninvasive diagnosis of liver cirrhosis[C]. Presented in 3rd heart center European symposium on ultrasound contrast imaging. Jan, 1998.
  • 9[9]Michelle L, Therese M. The potential role of ultrasound contrast agents I n the liver [J]. Applied Radiology, 1997, 26(1):13-18.
  • 10[10]Plew J, Sanki J, Young N, et al. Early experience in the use of Levovist u ltrasound contrast in the evaluation of liver masses[J]. Australia Radiol, 200 0, 44(1):28-31.

共引文献12

临床超声医学杂志
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部